Increased retinoic acid receptor-β4 correlates in vivo with reduced retinoic acid receptor-β2 in esophageal squamous cell carcinoma

Xiao Chun Xu, J. Jack Lee, Tsung Teh Wu, Ashraful Hoque, Jeffer A. Ajani, Scott M. Lippman

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Different retinoic acid receptor-β (RAR-β) isoforms seem to have contrasting biological effects in human carcinogenesis. Both in vitro and in vivo data indicate that RAR-β2 expression is frequently lost or reduced (and transfecting RAR-β2 suppresses growth and promotes apoptosis) in various cancer cells and tissues, whereas RAR-β4 expression is increased in several cancer cell lines. To clarify the effects of different RAR-β isoforms in esophageal carcinogenesis, we used real-time quantitative reverse transcription-PCR to assess in vivo RAR-β mRNA levels in specimens of normal and malignant human esophageal tissue, comparing these levels with each other and the expressions of other genes. RAR- β2 mRNA expression was significantly reduced (i.e., lower in cancer than normal tissue) in 67% (18 of 27, P = 0.001) and RAR- β4 mRNA was increased in 52% (14 of 27, P = 0.054) of our esophageal cancer cases. The expressions of RAR-β1, chicken ovalbumin upstream promoter-transcription factor-I (COUP-TFI), COUP-TFII, and peroxisome proliferator-activated receptor-γ (PPAR-γ) mRNA were reduced, whereas epidermal growth factor receptor and cyclin D1 expressions were increased in tumor compared with in normal tissues. Reduced RAR-β2 expression correlated with increased RAR- β4 expression (P = 0.002) and with the suppression of COUP-TFI and COUP-TFII (P = 0.050 and 0.023, respectively) in tumor samples. These are the first in vivo expression patterns of RAR-β2 and RAR-β4 reported in humans or animals and support the in vitro data on these isoforms and their contrasting biological effects in human carcinogenesis.

Original languageEnglish (US)
Pages (from-to)826-829
Number of pages4
JournalCancer Epidemiology Biomarkers and Prevention
Volume14
Issue number4
DOIs
StatePublished - Apr 2005
Externally publishedYes

Fingerprint

Retinoic Acid Receptors
COUP Transcription Factor I
Messenger RNA
Protein Isoforms
Carcinogenesis
Neoplasms
Esophageal Squamous Cell Carcinoma
Peroxisome Proliferator-Activated Receptors
Cyclin D1
Esophageal Neoplasms
Epidermal Growth Factor Receptor
Reverse Transcription

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Increased retinoic acid receptor-β4 correlates in vivo with reduced retinoic acid receptor-β2 in esophageal squamous cell carcinoma. / Xu, Xiao Chun; Lee, J. Jack; Wu, Tsung Teh; Hoque, Ashraful; Ajani, Jeffer A.; Lippman, Scott M.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 14, No. 4, 04.2005, p. 826-829.

Research output: Contribution to journalArticle

Xu, Xiao Chun ; Lee, J. Jack ; Wu, Tsung Teh ; Hoque, Ashraful ; Ajani, Jeffer A. ; Lippman, Scott M. / Increased retinoic acid receptor-β4 correlates in vivo with reduced retinoic acid receptor-β2 in esophageal squamous cell carcinoma. In: Cancer Epidemiology Biomarkers and Prevention. 2005 ; Vol. 14, No. 4. pp. 826-829.
@article{b602c3661e724e86821e3af400681536,
title = "Increased retinoic acid receptor-β4 correlates in vivo with reduced retinoic acid receptor-β2 in esophageal squamous cell carcinoma",
abstract = "Different retinoic acid receptor-β (RAR-β) isoforms seem to have contrasting biological effects in human carcinogenesis. Both in vitro and in vivo data indicate that RAR-β2 expression is frequently lost or reduced (and transfecting RAR-β2 suppresses growth and promotes apoptosis) in various cancer cells and tissues, whereas RAR-β4 expression is increased in several cancer cell lines. To clarify the effects of different RAR-β isoforms in esophageal carcinogenesis, we used real-time quantitative reverse transcription-PCR to assess in vivo RAR-β mRNA levels in specimens of normal and malignant human esophageal tissue, comparing these levels with each other and the expressions of other genes. RAR- β2 mRNA expression was significantly reduced (i.e., lower in cancer than normal tissue) in 67{\%} (18 of 27, P = 0.001) and RAR- β4 mRNA was increased in 52{\%} (14 of 27, P = 0.054) of our esophageal cancer cases. The expressions of RAR-β1, chicken ovalbumin upstream promoter-transcription factor-I (COUP-TFI), COUP-TFII, and peroxisome proliferator-activated receptor-γ (PPAR-γ) mRNA were reduced, whereas epidermal growth factor receptor and cyclin D1 expressions were increased in tumor compared with in normal tissues. Reduced RAR-β2 expression correlated with increased RAR- β4 expression (P = 0.002) and with the suppression of COUP-TFI and COUP-TFII (P = 0.050 and 0.023, respectively) in tumor samples. These are the first in vivo expression patterns of RAR-β2 and RAR-β4 reported in humans or animals and support the in vitro data on these isoforms and their contrasting biological effects in human carcinogenesis.",
author = "Xu, {Xiao Chun} and Lee, {J. Jack} and Wu, {Tsung Teh} and Ashraful Hoque and Ajani, {Jeffer A.} and Lippman, {Scott M.}",
year = "2005",
month = "4",
doi = "10.1158/1055-9965.EPI-04-0500",
language = "English (US)",
volume = "14",
pages = "826--829",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Increased retinoic acid receptor-β4 correlates in vivo with reduced retinoic acid receptor-β2 in esophageal squamous cell carcinoma

AU - Xu, Xiao Chun

AU - Lee, J. Jack

AU - Wu, Tsung Teh

AU - Hoque, Ashraful

AU - Ajani, Jeffer A.

AU - Lippman, Scott M.

PY - 2005/4

Y1 - 2005/4

N2 - Different retinoic acid receptor-β (RAR-β) isoforms seem to have contrasting biological effects in human carcinogenesis. Both in vitro and in vivo data indicate that RAR-β2 expression is frequently lost or reduced (and transfecting RAR-β2 suppresses growth and promotes apoptosis) in various cancer cells and tissues, whereas RAR-β4 expression is increased in several cancer cell lines. To clarify the effects of different RAR-β isoforms in esophageal carcinogenesis, we used real-time quantitative reverse transcription-PCR to assess in vivo RAR-β mRNA levels in specimens of normal and malignant human esophageal tissue, comparing these levels with each other and the expressions of other genes. RAR- β2 mRNA expression was significantly reduced (i.e., lower in cancer than normal tissue) in 67% (18 of 27, P = 0.001) and RAR- β4 mRNA was increased in 52% (14 of 27, P = 0.054) of our esophageal cancer cases. The expressions of RAR-β1, chicken ovalbumin upstream promoter-transcription factor-I (COUP-TFI), COUP-TFII, and peroxisome proliferator-activated receptor-γ (PPAR-γ) mRNA were reduced, whereas epidermal growth factor receptor and cyclin D1 expressions were increased in tumor compared with in normal tissues. Reduced RAR-β2 expression correlated with increased RAR- β4 expression (P = 0.002) and with the suppression of COUP-TFI and COUP-TFII (P = 0.050 and 0.023, respectively) in tumor samples. These are the first in vivo expression patterns of RAR-β2 and RAR-β4 reported in humans or animals and support the in vitro data on these isoforms and their contrasting biological effects in human carcinogenesis.

AB - Different retinoic acid receptor-β (RAR-β) isoforms seem to have contrasting biological effects in human carcinogenesis. Both in vitro and in vivo data indicate that RAR-β2 expression is frequently lost or reduced (and transfecting RAR-β2 suppresses growth and promotes apoptosis) in various cancer cells and tissues, whereas RAR-β4 expression is increased in several cancer cell lines. To clarify the effects of different RAR-β isoforms in esophageal carcinogenesis, we used real-time quantitative reverse transcription-PCR to assess in vivo RAR-β mRNA levels in specimens of normal and malignant human esophageal tissue, comparing these levels with each other and the expressions of other genes. RAR- β2 mRNA expression was significantly reduced (i.e., lower in cancer than normal tissue) in 67% (18 of 27, P = 0.001) and RAR- β4 mRNA was increased in 52% (14 of 27, P = 0.054) of our esophageal cancer cases. The expressions of RAR-β1, chicken ovalbumin upstream promoter-transcription factor-I (COUP-TFI), COUP-TFII, and peroxisome proliferator-activated receptor-γ (PPAR-γ) mRNA were reduced, whereas epidermal growth factor receptor and cyclin D1 expressions were increased in tumor compared with in normal tissues. Reduced RAR-β2 expression correlated with increased RAR- β4 expression (P = 0.002) and with the suppression of COUP-TFI and COUP-TFII (P = 0.050 and 0.023, respectively) in tumor samples. These are the first in vivo expression patterns of RAR-β2 and RAR-β4 reported in humans or animals and support the in vitro data on these isoforms and their contrasting biological effects in human carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=16444379652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16444379652&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-04-0500

DO - 10.1158/1055-9965.EPI-04-0500

M3 - Article

C2 - 15824151

AN - SCOPUS:16444379652

VL - 14

SP - 826

EP - 829

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 4

ER -